Literature DB >> 16097952

Role of MKK3 and p38 MAPK in cytokine-induced death of insulin-producing cells.

Natalia Makeeva1, Jason W Myers, Nils Welsh.   

Abstract

The aim of the present investigation was to elucidate further the importance of p38 MAPK (mitogen-activated protein kinase) in nitric oxide- and cytokine-induced beta-cell death. For this purpose, isolated human islets were treated with d-siRNA (diced small interfering RNA) and then exposed to the nitric oxide donor DETA/NONOate [2,2'-(hydroxynitrosohydrazono)bis-ethanamine]. We observed that cells treated with p38alpha-specific d-siRNA, but not with d-siRNA targeting GL3 (a firefly luciferase siRNA plasmid) or PKCdelta (protein kinase Cdelta), were protected against nitric oxide-induced death. This was paralleled by an increased level of Bcl-XL (B-cell leukaemia/lymphoma-X long). For an in-depth study of the mechanisms of p38 activation, MKK3 (MAPK kinase 3), MKK6 and their dominant-negative mutants were overexpressed in insulin-producing RIN-5AH cells. In transient transfections, MKK3 overexpression resulted in increased p38 phosphorylation, whereas in stable MKK3-overexpressing RIN-5AH clones, the protein levels of p38 and JNK (c-Jun N-terminal kinase) were decreased, resulting in unaffected phospho-p38 levels. In addition, a long-term MKK3 overexpression did not affect cell death rates in response to the cytokines interleukin-1beta and interferon-gamma, whereas a short-term MKK3 expression resulted in increased cytokine-induced RIN-5AH cell death. The MKK3-potentiating effect on cytokine-induced cell death was abolished by a nitric oxide synthase inhibitor, and MKK3-stimulated p38 phosphorylation was enhanced by inhibitors of phosphatases. Finally, as the dominant-negative mutant of MKK3 did not affect cytokine-induced p38 phosphorylation, and as wild-type MKK3 did not influence p38 autophosphorylation, it may be that p38 is activated by MKK3/6-independent pathways in response to cytokines and nitric oxide. In addition, it is likely that a long-term increase in p38 activity is counteracted by both a decreased expression of the p38, JNK and p42 genes as well as an increased dephosphorylation of p38.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16097952      PMCID: PMC1383671          DOI: 10.1042/BJ20050814

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

1.  The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2.

Authors:  Zhimin Lu; Shuichan Xu; Claudio Joazeiro; Melanie H Cobb; Tony Hunter
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

2.  Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.

Authors:  Zhengfan Jiang; Jun Ninomiya-Tsuji; Youcun Qian; Kunihiro Matsumoto; Xiaoxia Li
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 3.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity.

Authors:  Rocky Pramanik; Xiaomei Qi; Stanley Borowicz; Divaker Choubey; Richard M Schultz; Jiahuai Han; Guan Chen
Journal:  J Biol Chem       Date:  2002-12-09       Impact factor: 5.157

5.  p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2.

Authors:  Narayan R Bhat; Douglas L Feinstein; Qin Shen; Aruna N Bhat
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

Review 6.  Mechanisms of caspase activation and inhibition during apoptosis.

Authors:  Yigong Shi
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

7.  Nicotinamide- and caspase-mediated inhibition of poly(ADP-ribose) polymerase are associated with p53-independent cell cycle (G2) arrest and apoptosis.

Authors:  Johan Saldeen; Linda Tillmar; Ella Karlsson; Nils Welsh
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

8.  SP600125, an inhibitor of c-jun N-terminal kinase, activates CREB by a p38 MAPK-mediated pathway.

Authors:  Dhara Vaishnav; Purevsuren Jambal; Jane E-B Reusch; Subbiah Pugazhenthi
Journal:  Biochem Biophys Res Commun       Date:  2003-08-08       Impact factor: 3.575

9.  Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38.

Authors:  D Margriet Ouwens; Nancy D de Ruiter; Gerard C M van der Zon; Andrew P Carter; Jan Schouten; Corina van der Burgt; Klaas Kooistra; Johannes L Bos; J Antonie Maassen; Hans van Dam
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

10.  Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.

Authors:  Nils Welsh; Natalia Makeeva; Michael Welsh
Journal:  Mol Med       Date:  2002-11       Impact factor: 6.354

View more
  12 in total

Review 1.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

2.  P38alpha-selective mitogen-activated protein kinase inhibitor for improvement of cultured human islet recovery.

Authors:  Keiko Omori; Ivan Todorov; Jonathan Shintaku; Jeffrey Rawson; Ismail H Al-Abdullah; Linda S Higgins; Satyanarayana Medicherla; Fouad Kandeel; Yoko Mullen
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

3.  Exendin-4 protects murine MIN6 pancreatic β-cells from interleukin-1β-induced apoptosis via the NF-κB pathway.

Authors:  X H Liu; Y P Wang; L X Wang; Z Chen; X Y Liu; L B Liu
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

4.  Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells.

Authors:  Toshiyuki Imasawa; Kentaro Koike; Isao Ishii; Jerold Chun; Yutaka Yatomi
Journal:  Biochem Biophys Res Commun       Date:  2010-01-12       Impact factor: 3.575

5.  Preventing p38 MAPK-mediated MafA degradation ameliorates β-cell dysfunction under oxidative stress.

Authors:  Ilham El Khattabi; Arun Sharma
Journal:  Mol Endocrinol       Date:  2013-05-09

6.  Role of TAB1 in nitric oxide-induced p38 activation in insulin-producing cells.

Authors:  Natalia Makeeva; Godfried M Roomans; Nils Welsh
Journal:  Int J Biol Sci       Date:  2006-11-25       Impact factor: 6.580

7.  MAPK kinase kinase-1 is essential for cytokine-induced c-Jun NH2-terminal kinase and nuclear factor-kappaB activation in human pancreatic islet cells.

Authors:  Dariush Mokhtari; Jason W Myers; Nils Welsh
Journal:  Diabetes       Date:  2008-04-16       Impact factor: 9.461

8.  T cells cooperate with palmitic acid in induction of beta cell apoptosis.

Authors:  Tamara Cvjetićanin; Ivana Stojanović; Gordana Timotijević; Stanislava Stosić-Grujicić; Djordje Miljković
Journal:  BMC Immunol       Date:  2009-05-22       Impact factor: 3.615

9.  Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.

Authors:  Grzegorz Sumara; Ivan Formentini; Stephan Collins; Izabela Sumara; Renata Windak; Bernd Bodenmiller; Reshma Ramracheya; Dorothée Caille; Huiping Jiang; Kenneth A Platt; Paolo Meda; Rudolf Aebersold; Patrik Rorsman; Romeo Ricci
Journal:  Cell       Date:  2009-01-08       Impact factor: 41.582

Review 10.  Kinase Signaling in Apoptosis Induced by Saturated Fatty Acids in Pancreatic β-Cells.

Authors:  Jan Šrámek; Vlasta Němcová-Fürstová; Jan Kovář
Journal:  Int J Mol Sci       Date:  2016-09-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.